Neonatal outcomes of non-vigorous neonates with meconium-stained amniotic fluid before and after change in tracheal suctioning recommendation

J Perinatol. 2022 Jun;42(6):769-774. doi: 10.1038/s41372-021-01287-0. Epub 2022 Jan 8.

Abstract

Objective: To evaluate the short-term outcomes of non-vigorous infants born through meconium-stained amniotic fluid (MSAF) before and after implementation of no-tracheal suctioning guidelines.

Study design: Single-center retrospective study of ≥36-week gestation neonates with MSAF.

Results: During routine-suction era (9/2013-12/2014), 280/2306 neonates (12%) were born through MSAF and 39 (14%) were non-vigorous. Thirty (77%) of non-vigorous infants underwent tracheal suctioning. In the no-suction era (1/2017-12/2018), 282/2918 neonates (9.7%) were born through MSAF and 30 (10.6%) were non-vigorous and one needed intubation. Admissions for meconium aspiration syndrome (15% vs 53%) and respiratory distress (18% vs 57%) were significantly higher among non-vigorous infants in the no-suction era.

Conclusions: In this single-center study, non-vigorous infants born through MSAF without routine-tracheal suctioning had a higher incidence of NICU admission for MAS and respiratory distress compared to the routine-suction era. Multicenter randomized trials evaluating tracheal suction in non-vigorous infants with MSAF are warranted.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Amniotic Fluid
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Meconium
  • Meconium Aspiration Syndrome* / therapy
  • Respiratory Distress Syndrome*
  • Retrospective Studies
  • Suction